Femasys News

Femasys | 10-Q: Quarterly report

Futu NewsMay 9 20:42 · Announcements

Femasys Q1 2024 GAAP EPS $(0.17) Beats $(0.19) Estimate, Sales $271.140K Miss $776.500K Estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. The company reported quarterly sales of $271.140 thousand w

BenzingaMay 9 20:41

Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140

08:34 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140

MT NewswiresMay 9 20:34

Femasys 1Q Sales $271,140 >FEMY

Femasys 1Q Sales $271,140 >FEMY

Dow JonesMay 9 20:31

Press Release: Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update

Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update -- Recruitment of the commercial team for our infertility portfolio and the pivotal trial of FemBloc

Dow JonesMay 9 20:30

Femasys Releases Updated Investor Presentation Information

TipRanksApr 24 21:22

Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential

TipRanksApr 3 03:45

Femasys Is Maintained at Buy by HC Wainwright & Co.

Femasys Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 1 18:54

Femasys Price Target Raised to $12.00/Share From $10.00 by HC Wainwright & Co.

Femasys Price Target Raised to $12.00/Share From $10.00 by HC Wainwright & Co.

Dow JonesApr 1 18:54

HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10 to $12.

BenzingaApr 1 18:43

Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceMar 31 21:06

Femasys Q4 EPS $(0.19) Beats $(0.21) Estimate, Sales $213.11K Miss $240.00K Estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 20.83 percent increase over losses of $(0.24) per s

BenzingaMar 29 11:38

Femasys GAAP EPS of -$0.93, Revenue of $1.07M

Seeking AlphaMar 29 04:55

Analysts Offer Insights on Healthcare Companies: Femasys (FEMY) and NextCure (NXTC)

TipRanksMar 22 02:30

Chardan Capital Reiterates Buy on Femasys, Maintains $12 Price Target

Chardan Capital analyst Keay Nakae reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

BenzingaMar 22 00:54

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape

Femasys Inc. (NASDAQ: FEMY) invites investors to join management in a Fireside Chat with Jones Trading Analyst Catherine Novack to discuss the current treatment landscape for infertility treatment in women.

GlobeNewswireMar 21 21:00

Femasys Is Maintained at Buy by JonesTrading

Femasys Is Maintained at Buy by JonesTrading

Dow JonesMar 21 20:28

Femasys Price Target Raised to $10.00/Share From $7.00 by JonesTrading

Femasys Price Target Raised to $10.00/Share From $7.00 by JonesTrading

Dow JonesMar 21 20:28

Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Femasys (FEMY), BioNTech SE (BNTX) and Annovis Bio (ANVS) with bullish sentiments.

TipRanksMar 21 18:31

HC Wainwright & Co. Reiterates Buy on Femasys, Maintains $10 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $10 price target.

BenzingaMar 21 18:29